{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:06:23Z","timestamp":1785305183615,"version":"3.55.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Rheumatic heart disease (RHD) is a critical problem in developing countries and is the cause of most of the cardiovascular adverse events in young people. In patients aged 50\u201370 years with RHD requiring mitral valve replacement (MVR), deciding between bioprosthetic and mechanical prosthetic valves remains controversial because few studies have defined the long-term outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>1,691 Patients aged 50\u201370 years with RHD who received mechanical mitral valve replacement (MVRm) or bioprosthetic mitral valve replacement (MVRb) were retrospectively reviewed in Fuwai hospital from 2010 to 2014. Follow-up ended 31\/12\/2021; median duration was 8.0 years [interquartile range (IQR), 7.7\u20138.3 years]. Propensity score matching at a 1:1 ratio for 24 baseline features between MVRm and MVRb yielded 300 patient pairs. The primary late outcome was postoperative mid- to long-term all-cause mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ten-year survival after MVR was 63.4% in the MVRm group and 63.7% in the MVRb group (HR, 0.91; 95% CI, 0.69\u20131.21; <jats:italic>P<\/jats:italic> = 0.528). The cumulative incidence of mitral valve reoperation was 0.0% in the MVRm group and 1.2% in the MVRb group (HR, 0.92; 95% CI, 0.69\u20131.21; <jats:italic>P<\/jats:italic> = 0.530). The cumulative incidence of stroke was 5.5% in the MVRm group and 6.1% in the MVRb group (HR, 0.89; 95% CI, 0.67\u20131.18; <jats:italic>P<\/jats:italic> = 0.430). The cumulative incidence of major bleeding events was 3.3% in the MVRm group and 3.4% in the MVRb group (HR, 0.92; 95% CI, 0.70\u20131.22; <jats:italic>P<\/jats:italic> = 0.560).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In patients aged 50\u201370 years with RHD who underwent mitral valve replacement, there was no significant difference on survival, stroke, mitral valve reoperation and major bleeding events at 10 years. These findings suggest mechanical mitral valve replacement may be a more reasonable alternative in patients aged 50\u201370 years with rheumatic heart disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.904958","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T05:12:12Z","timestamp":1653973932000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Bioprosthetic vs. Mechanical Mitral Valve Replacement for Rheumatic Heart Disease in Patients Aged 50\u201370 Years"],"prefix":"10.3389","volume":"9","author":[{"given":"Jun","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(11)61171-9","article-title":"Rheumatic heart disease","volume":"379","author":"Marijon","year":"2012","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e20180041","DOI":"10.1590\/0037-8682-0041-2019","article-title":"Rheumatic heart disease in the modern era: recent developments and current challenges","volume":"52","author":"Leal","year":"2019","journal-title":"Rev Soc Bras Med Trop."},{"key":"B3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s12013-015-0552-5","article-title":"Rheumatic heart disease: causes, symptoms, and treatments","volume":"72","author":"Liu","year":"2015","journal-title":"Cell Biochem Biophys."},{"key":"B4","doi-asserted-by":"publisher","first-page":"32459","DOI":"10.1016\/j.jtcvs.2020.07.117","article-title":"Mitral valve repair versus replacement in patients with rheumatic heart disease","volume":"5223","author":"Chen","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC Focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the american college of cardiology\/American heart association task force on clinical practice guidelines","volume":"135","author":"Nishimura","year":"2017","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"00512","DOI":"10.1016\/j.jtcvs.2021.03.033","article-title":"Bioprosthetic vs. mechanical mitral valve replacements in patients with rheumatic heart disease","volume":"5223","author":"Chen","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1017\/S1047951109003680","article-title":"Comparison of mechanical and biological prostheses when used to replace heart valves in children and adolescents with rheumatic fever","volume":"19","author":"Travancas","year":"2009","journal-title":"Cardiol Young."},{"key":"B9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1749-8090-6-57","article-title":"Outcome of left heart mechanical valve replacement in West African children\u2014A 15-year retrospective study","volume":"6","author":"Edwin","year":"2011","journal-title":"J Cardiothorac Surg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.jtcvs.2020.02.139","article-title":"Contemporary outcomes of aortic and mitral valve surgery for rheumatic heart disease in sub-Saharan Africa","volume":"162","author":"Tamirat","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1001\/jamacardio.2017.5123","article-title":"Guideline update on evaluation and selection of prosthetic valves","volume":"3","author":"Nishimura","year":"2018","journal-title":"JAMA Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nrcardio.2010.202","article-title":"Epidemiology of valvular heart disease in the adult","volume":"8","author":"Iung","year":"2011","journal-title":"Nat Rev Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1056\/NEJMoa1613792","article-title":"Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement","volume":"377","author":"Goldstone","year":"2017","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1001\/jama.2015.3164","article-title":"Survival and outcomes following bioprosthetic vs. mechanical mitral valve replacement in patients aged 50 to 69 years","volume":"313","author":"Chikwe","year":"2015","journal-title":"JAMA."},{"key":"B15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ejcts.2006.06.013","article-title":"Mechanical vs. bioprosthetic valve replacement in middle-aged patients","volume":"30","author":"Kulik","year":"2006","journal-title":"Eur J Cardiothorac Surg."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/clc.23407","article-title":"Bioprosthetic vs. mechanical mitral valve replacement for infective endocarditis in patients aged 50 to 69 years","volume":"43","author":"Hu","year":"2020","journal-title":"Clin Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.athoracsur.2009.01.064","article-title":"Trends in mitral valve surgery in the united states: results from the society of thoracic surgeons adult cardiac database","volume":"87","author":"Gammie","year":"2009","journal-title":"Ann Thorac Surg."},{"key":"B18","first-page":"185","article-title":"Transcatheter mitral valve replacement for degenerated bioprosthetic valves and failed annuloplasty rings","volume":"37","author":"Schaefer","year":"2020","journal-title":"Surg Technol Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/j.jacc.2015.09.015","article-title":"Transcatheter valve-in-valve and valve-in-ring for treating aortic and mitral surgical prosthetic dysfunction","volume":"66","author":"Paradis","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/eurheartj\/ehy590","article-title":"Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification","volume":"40","author":"Yoon","year":"2019","journal-title":"Eur Heart J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1365-2141.2004.05154.x","article-title":"Point of care testing for INR monitoring: where are we now?","volume":"127","author":"Murray","year":"2004","journal-title":"Br J Haematol."},{"key":"B22","first-page":"e465","article-title":"Monitoring of international normalized ratios: comparison of community nurses with family physicians","volume":"58","author":"Levine","year":"2012","journal-title":"Can Fam Physician."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.904958\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T05:12:18Z","timestamp":1653973938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.904958\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":22,"alternative-id":["10.3389\/fcvm.2022.904958"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.904958","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]},"article-number":"904958"}}